Home/Filings/4/0001610717-25-000378
4//SEC Filing

Aurora Daljit Singh 4

Accession 0001610717-25-000378

CIK 0001885522other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:39 PM ET

Size

6.0 KB

Accession

0001610717-25-000378

Insider Transaction Report

Form 4
Period: 2025-11-11
Transactions
  • Sale

    Common Stock

    2025-11-11$2.68/sh114,703$307,0260 total(indirect: See footnote)
Holdings
  • Common Stock

    88,935
Footnotes (3)
  • [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on April 22, 2024.
  • [F2]This transaction was executed in multiple trades in prices ranging from $2.65 to $2.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]Shares held by Aurora Family Trust.

Documents

1 file

Issuer

Neumora Therapeutics, Inc.

CIK 0001885522

Entity typeother

Related Parties

1
  • filerCIK 0001793971

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:39 PM ET
Size
6.0 KB